Philip Worboys

665 total citations
14 papers, 558 citations indexed

About

Philip Worboys is a scholar working on Pharmacology, Pharmacology and Oncology. According to data from OpenAlex, Philip Worboys has authored 14 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 4 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in Philip Worboys's work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Philip Worboys is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Philip Worboys collaborates with scholars based in United Kingdom and United States. Philip Worboys's co-authors include A.F. Bradbury, J. Brian Houston, Paul Weller, Mario Monshouwer, Xingrong Liu, Helen Yeo, David Carlile, Steven L. Barriere, Bindi Sohal and Paul Scott‐Stevens and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Drug Metabolism and Disposition and European Journal of Clinical Pharmacology.

In The Last Decade

Philip Worboys

14 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Worboys United Kingdom	13	228	168	143	84	78	14	558
Daniel R. Mudra United States	11	270 1.2×	200 1.2×	217 1.5×	55 0.7×	58 0.7×	18	647
Louis Leung United States	16	287 1.3×	163 1.0×	195 1.4×	124 1.5×	55 0.7×	24	754
Lisa A. Shipley United States	12	235 1.0×	138 0.8×	193 1.3×	52 0.6×	81 1.0×	22	581
David L. Bourdet United States	14	194 0.9×	317 1.9×	182 1.3×	75 0.9×	40 0.5×	37	821
Cen Guo United States	13	166 0.7×	282 1.7×	155 1.1×	52 0.6×	33 0.4×	25	634
Jeanine Ballard United States	9	112 0.5×	99 0.6×	152 1.1×	37 0.4×	53 0.7×	19	383
Masashi Yabuki Japan	13	250 1.1×	232 1.4×	155 1.1×	54 0.6×	17 0.2×	36	574
Kenji Tabata Japan	14	214 0.9×	212 1.3×	113 0.8×	90 1.1×	17 0.2×	29	561
Su-Er W. Huskey United States	11	194 0.9×	127 0.8×	133 0.9×	37 0.4×	30 0.4×	13	548
Denis Projean Canada	7	183 0.8×	122 0.7×	86 0.6×	51 0.6×	27 0.3×	12	405

Countries citing papers authored by Philip Worboys

Since Specialization

Citations

This map shows the geographic impact of Philip Worboys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Worboys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Worboys more than expected).

Fields of papers citing papers by Philip Worboys

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Worboys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Worboys. The network helps show where Philip Worboys may publish in the future.

Co-authorship network of co-authors of Philip Worboys

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Worboys. A scholar is included among the top collaborators of Philip Worboys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Worboys. Philip Worboys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Worboys, Philip, Shekman Wong, & Steven L. Barriere. (2015). Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment. European Journal of Clinical Pharmacology. 71(6). 707–714. 20 indexed citations

Bolleddula, Jayaprakasam, Kevin DeMent, James P. Driscoll, et al.. (2014). Biotransformation and bioactivation reactions of alicyclic amines in drug molecules. Drug Metabolism Reviews. 46(3). 379–419. 60 indexed citations

McConeghy, Kevin W., et al.. (2014). Variability in Telavancin Cross-Reactivity among Vancomycin Immunoassays. Antimicrobial Agents and Chemotherapy. 58(12). 7093–7097. 12 indexed citations

Samara, Emil, Jeng‐Pyng Shaw, Steven L. Barriere, Shekman Wong, & Philip Worboys. (2012). Population Pharmacokinetics of Telavancin in Healthy Subjects and Patients with Infections. Antimicrobial Agents and Chemotherapy. 56(4). 2067–2073. 24 indexed citations

Worboys, Philip, et al.. (2010). Scaling In Vivo Pharmacokinetics from In Vitro Metabolic Stability Data in Drug Discovery. Combinatorial Chemistry & High Throughput Screening. 13(2). 159–169. 12 indexed citations

Liu, Xingrong, et al.. (2008). Unbound Drug Concentration in Brain Homogenate and Cerebral Spinal Fluid at Steady State as a Surrogate for Unbound Concentration in Brain Interstitial Fluid. Drug Metabolism and Disposition. 37(4). 787–793. 141 indexed citations

Scott‐Stevens, Paul, John Atack, Bindi Sohal, & Philip Worboys. (2004). Rodent pharmacokinetics and receptor occupancy of the GABA_A receptor subtype selective benzodiazepine site ligand L‐838417. Biopharmaceutics & Drug Disposition. 26(1). 13–20. 44 indexed citations

Worboys, Philip & David Carlile. (2001). Implications and consequences of enzyme induction on preclinical and clinical drug development. Xenobiotica. 31(8-9). 539–556. 29 indexed citations

Renwick, A. B., David F. Lewis, Dominic Surry, et al.. (2001). Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin by human hepatic CYP isoforms: evidence for selectivity towards CYP3A4. Xenobiotica. 31(4). 187–204. 29 indexed citations

10.

Worboys, Philip, et al.. (2000). Regioselective and stereoselective hydroxylations of warfarin in human liver microsomes and cDNA expressed cytochrome P450.. Research Explorer (The University of Manchester). 1 indexed citations

11.

Worboys, Philip, A.F. Bradbury, & J. Brian Houston. (1997). Kinetics of drug metabolism in rat liver slices. III. Relationship between metabolic clearance and slice uptake rate.. PubMed. 25(4). 460–7. 63 indexed citations

12.

Worboys, Philip, B Brennan, A.F. Bradbury, & J. Brian Houston. (1996). Metabolite kinetics of ondansetron in rat. Comparison of hepatic microsomes, isolated hepatocytes and liver slices, with in vivo disposition. Xenobiotica. 26(9). 897–907. 30 indexed citations

13.

Worboys, Philip, A.F. Bradbury, & J. Brian Houston. (1996). Kinetics of drug metabolism in rat liver slices. II. Comparison of clearance by liver slices and freshly isolated hepatocytes.. Drug Metabolism and Disposition. 24(6). 676–681. 47 indexed citations

14.

Worboys, Philip, A.F. Bradbury, & J. Brian Houston. (1995). Kinetics of drug metabolism in rat liver slices. Rates of oxidation of ethoxycoumarin and tolbutamide, examples of high- and low-clearance compounds.. Drug Metabolism and Disposition. 23(3). 393–397. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact